Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease.

ABSTRACT:

Background

The International Consortium for Health Outcomes Measurement has selected the self-administered comorbidity questionnaire (SCQ) to adjust case-mix when comparing outcomes of inflammatory bowel disease (IBD) treatment between healthcare providers. However, the SCQ has not been validated for use in IBD patients.

Objectives

We assessed the validity of the SCQ for measuring comorbidities in IBD patients.

Design

Cohort study.

Methods

We assessed the criterion validity of the SCQ for IBD patients by comparing patient-reported and clinician-reported comorbidities (as noted in the electronic health record) of the 13 diseases of the SCQ using Cohen's kappa. Construct validity was assessed using the Spearman correlation coefficient between the SCQ and the Char

SUBMITTER: van Linschoten RCA 

PROVIDER: S-EPMC10591493 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature